Traws Pharma, Inc.

Q2 2026 13F Holders

Symbol
TRAW
CUSIP
68232V884
Type
Equity
Class
COM NEW
Num filings
33
Total reported value, excl. options
$5.19 M
Manager Report Date Value ($000) Shares Option Type